We arrived at the emergency vet at 1 a.m. Our 10-month-old kitten, Pippin, had started breathing oddly earlier in the day but we thought…
Last April, the Centers for Medicare and Medicaid Services (CMS) decided to limit the coverage of the controversial Alzheimer’s drug Aduhelm and similar drugs…
During the height of the AIDS crisis 35 years ago, a few hundred people gathered one night in the NYC Lesbian and Gay Community…
How much does Aduhelm cost? Aduhelm costs an average of $28,200 per year for patients who receive treatment without insurance coverage. But if you…
Michele Hall, an attorney working in her county sheriff’s office, first noticed that something was off about her cognitive health when she found she…
The media is reporting that recent fraud allegations undermine the leading theory about the cause of Alzheimer’s. But some of the field’s most established…
According to an Eisai press release, the U.S. Food and Drug Administration has now granted priority review to a new anti-amyloid drug by Biogen…
Drugmaker Biogen had high hopes for its landmark Alzheimer’s medication Aduhelm. But ever since its controversial July 2021 approval by the Food and Drug…
A few weeks ago, my husband Tim and I were sitting at our kitchen counter, chatting over dinner and looking through the day’s mail….
Biogen announced that the Food and Drug Administration (FDA) has updated the label for its anti-amyloid drug Aduhelm. These changes will add an additional…
Biogen has abandoned its application for the approval of anti-amyloid Alzheimer’s therapy Aduhelm (aducanumab) with European regulatory agencies. This marks yet another setback arises…
In February of this year, the Centers for Medicare and Medicaid Services (CMS) released a confusing proposal to dramatically limit insurance coverage for Aduhelm,…
I’m a 52-year-old pediatrician diagnosed with younger-onset Alzheimer’s disease in November 2020. Alzheimer’s is not my story, but now it’s my life. This is what…
“It’s been very confusing,” said Pam Montana, an advocate for Alzheimer’s who has participated in several clinical trials herself, adding that the recent memo…
Here’s how VOA’s 5 founders — including reporter Phil Gutis — responded to recent Aduhelm Medicare announcement. A few months ago, I received an…